Funded Startups in West Lafayette
West Lafayette’s newest activity spans from 2022-02-10 (AnalySwift, Grant, $100K) through 2025-10-17 (Neurava, Venture, $2M), with the latest disclosed rou…
West Lafayette’s newest activity spans from 2022-02-10 (AnalySwift, Grant, $100K) through 2025-10-17 (Neurava, Venture, $2M), with the latest disclosed round on 2025-10-17. Most disclosed amounts cluster in the roughly $1M–$15M range, but Eradivir’s $10M (2024-09-23) and Vibronix’s $14M (2024-06-24) sit well above the rest; the only disclosed round above $10M is Vibronix’s $14M. Sector concentration is notable: Biotechnology appears in 4 of 12 entries (Adipo Therapeutics at $5M on 2024-12-11; Amplified Sciences at $3M on 2024-11-25; NutraMaize at $460K on 2024-01-09; MorphImmune at $15M on 2023-05-16), and multiple rounds land in a tight 2024 window (June–December 2024 contains 6 of the 12 rows).
On stage signaling, “Series Unknown” appears 5 times and “undisclosed” appears once (Blue Wave AI Labs, 2023-06-10), making disclosed comparisons uneven across time and rounds. An outlier in visibility is Blue Wave AI Labs: despite being an AI entry in 2023-06-10, its round is undisclosed, whereas the smallest disclosed amount is AnalySwift’s $100K on 2022-02-10.
Most recent rounds
12 shownRelated listings
Frequently asked
What stands out in round size, and is there a clear gap between the largest disclosed round and the rest?
The largest disclosed amount is MorphImmune’s $15M (2023-05-16). That level is well above the next-largest disclosed rounds of Vibronix’s $14M (2024-06-24) and Eradivir’s $10M (2024-09-23), while several other rounds sit at $5M or below (e.g., Wavelogix $1M on 2024-10-02; NutraMaize $460K on 2024-01-09).
Do the most recent rounds cluster in a narrow time window, or are they spread out evenly across years?
They cluster in 2024: 6 of the 12 rows fall between 2024-06-24 (Vibronix) and 2024-12-11 (Adipo Therapeutics). Earlier activity appears in 2022–2023 (e.g., AnalySwift $100K on 2022-02-10; MorphImmune $15M on 2023-05-16), but the density is clearly higher in late 2024.
Which sectors appear most often, and does the list skew toward any one category?
Biotechnology is the most repeated sector at 4 of 12 entries (Adipo Therapeutics $5M on 2024-12-11; Amplified Sciences $3M on 2024-11-25; NutraMaize $460K on 2024-01-09; MorphImmune $15M on 2023-05-16). Health Care accounts for 3 entries (Neurava $2M on 2025-10-17; Vibronix $14M on 2024-06-24; Vasc-Alert $160K on 2022-12-07), while AI shows up once (Blue Wave AI Labs, 2023-06-10, undisclosed).
How much of the dataset has missing or non-comparable round-size signals due to “Series Unknown” or undisclosed amounts?
“Series Unknown” appears in 5 of 12 rows (Neurava is Venture - Series Unknown; Adipo Therapeutics; Wavelogix; NutraMaize; Blue Wave AI Labs). Separately, one company has an undisclosed amount: Blue Wave AI Labs (2023-06-10), so its round can’t be compared by disclosed size against entries like Vibronix $14M (2024-06-24) or Eradivir $10M (2024-09-23).
What stage mix dominates, and are the largest disclosed rounds concentrated in a specific stage?
Seed appears 3 times (W3i Software $2M on 2025-03-12; Amplified Sciences $3M on 2024-11-25; Vasc-Alert $160K on 2022-12-07). Series Unknown appears 5 times, which is the largest share, while the biggest disclosed amounts are split across stages: MorphImmune’s $15M is Series Unknown (2023-05-16), Vibronix’s $14M is Series A (2024-06-24), and Eradivir’s $10M is Series A (2024-09-23).
Are there meaningful outliers beyond size, such as unusually small disclosed rounds or missing amounts?
Yes: the smallest disclosed amount is AnalySwift’s $100K (Grant, 2022-02-10), which is far below most other disclosed rounds. Additionally, Blue Wave AI Labs (Artificial Intelligence, 2023-06-10) is an outlier in comparability because its round amount is undisclosed, unlike neighboring biotech and health care entries with disclosed figures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.